** Shares of medical diagnostics co Lantheus Holdings LNTH.O fall 20% to over 2-month low of $83.71
** Co forecast 2025 sales to be between $1.55 bln and $1.59 bln; analysts were expecting 2025 sales to be $1.59 bln - data compiled by LSEG
** Co forecast 2025 adj. EPS between $6.60 and $6.70; analysts were expecting it to be $7.08/shr
** Co posts Q1 sales of $372.8 mln, below analysts' est. of $379 mln
** Reports Q1 adj. profit of $1.53/shr, below est. of $1.66/shr
** Including session moves, stock down 7% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。